Government Partnering With Providers, Caregivers, Patients to Ensure 
Appropriate Use of Antipsychotic Medications

On May 30, CMS Acting Administrator Marilyn Tavenner announced the Partnership 
to Improve Dementia Care, an initiative to ensure appropriate care and use of 
antipsychotic medications for nursing home patients. This partnership - among 
federal and state partners, nursing homes and other providers, advocacy groups 
and caregivers - has set a national goal of reducing use of antipsychotic drugs 
in nursing home residents by 15 percent by the end of 2012.

Unnecessary antipsychotic drug use is a significant challenge in ensuring 
appropriate dementia care. CMS data show that in 2010 more than 17 percent of 
nursing home patients had daily doses exceeding recommended levels.

CMS and industry and advocacy partners are taking several steps to achieve this 
goal of improved care:

§  Enhanced training: CMS has developed Hand in Hand, a training series for 
nursing homes that emphasizes person-centered care, prevention of abuse, and 
high-quality care for residents. CMS is also providing training focused on 
behavioral health to state and federal surveyors;

§  Increased transparency: CMS is making data on each nursing home's 
antipsychotic drug use available on Nursing Home Compare starting in July of 
this year, and will update this data;

§  Alternatives to antipsychotic medication: CMS is emphasizing 
non-pharmacological alternatives for nursing home residents, including 
potential approaches such as consistent staff assignments, increased exercise 
or time outdoors, monitoring and managing acute and chronic pain, and planning 
individualized activities.

These efforts will help achieve the 15 percent reduction goal by the end of 
this year. In addition, to address this challenge in the long-term CMS is 
conducting research to better understand the decision to use or not to use 
antipsychotic drugs in residents with dementia.  A study is underway in 20 to 
25 nursing homes, evaluating this decision-making process. Findings will be 
used to target and implement approaches to improve the overall management of 
residents with dementia, including reducing the use of antipsychotic drugs in 
this population.

Full text of this excerpted CMS press 
release<http://www.cms.gov/apps/media/press/release.asp?Counter=4368&intNumPerPage=10&checkDate=&checkKey=&srchType=1&numDays=3500&srchOpt=0&srchData=&keywordType=All&chkNewsType=1%2C+2%2C+3%2C+4%2C+5&intPage=&showAll=&pYear=&year=&desc=&cboOrder=date>
 (issued May 30).

________________________________

If you know someone who would like to subscribe to a Medicare Fee-For-Service 
(FFS) provider listserv, go to 
http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads//MailingLists_FactSheet.pdf<http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/MailingLists_FactSheet.pdf>
 .



If you would like to unsubscribe from a specific provider listserv, please go 
to (https://list.nih.gov/cgi-bin/wa.exe?INDEX) to unsubscribe or to leave the 
appropriate listserv.



Please DO NOT respond to this email. This email is a service of CMS and routed 
through an electronic mail server to communicate Medicare policy and 
operational changes and/or updates. Responses to this email are not routed to 
CMS personnel. Inquiries may be sent by going to 
(http://www.cms.gov/About-CMS/Agency-Information/ContactCMS/index.html).   
Thank you.


Reply via email to